Definium Therapeutics Statistics
Total Valuation
DFTX has a market cap or net worth of $5.81 billion. The enterprise value is $4.77 billion.
| Market Cap | 5.81B |
| Enterprise Value | 4.77B |
Important Dates
The last earnings date was Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DFTX has 134.37 million shares outstanding. The number of shares has increased by 22.22% in one year.
| Current Share Class | 134.37M |
| Shares Outstanding | 134.37M |
| Shares Change (YoY) | +22.22% |
| Shares Change (QoQ) | +1.74% |
| Owned by Insiders (%) | 1.99% |
| Owned by Institutions (%) | 80.51% |
| Float | 124.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 6.33 |
| P/TBV Ratio | 6.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.95, with a Debt / Equity ratio of 0.04.
| Current Ratio | 6.95 |
| Quick Ratio | 6.89 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -45.33 |
Financial Efficiency
Return on equity (ROE) is -64.09% and return on invested capital (ROIC) is -24.06%.
| Return on Equity (ROE) | -64.09% |
| Return on Assets (ROA) | -20.64% |
| Return on Invested Capital (ROIC) | -24.06% |
| Return on Capital Employed (ROCE) | -23.81% |
| Weighted Average Cost of Capital (WACC) | 16.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.34M |
| Employee Count | 106 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +324.63% in the last 52 weeks. The beta is 2.26, so DFTX's price volatility has been higher than the market average.
| Beta (5Y) | 2.26 |
| 52-Week Price Change | +324.63% |
| 50-Day Moving Average | 42.01 |
| 200-Day Moving Average | 23.62 |
| Relative Strength Index (RSI) | 49.48 |
| Average Volume (20 Days) | 2,276,150 |
Short Selling Information
The latest short interest is 10.74 million, so 7.99% of the outstanding shares have been sold short.
| Short Interest | 10.74M |
| Short Previous Month | 10.64M |
| Short % of Shares Out | 7.99% |
| Short % of Float | 8.63% |
| Short Ratio (days to cover) | 5.24 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -227.54M |
| Pretax Income | -353.79M |
| Net Income | -353.79M |
| EBITDA | n/a |
| EBIT | -227.54M |
| Earnings Per Share (EPS) | -$3.48 |
Balance Sheet
The company has $1.08 billion in cash and $36.47 million in debt, with a net cash position of $1.05 billion or $7.80 per share.
| Cash & Cash Equivalents | 1.08B |
| Total Debt | 36.47M |
| Net Cash | 1.05B |
| Net Cash Per Share | $7.80 |
| Equity (Book Value) | 918.68M |
| Book Value Per Share | 6.84 |
| Working Capital | 934.90M |
Cash Flow
| Operating Cash Flow | -167.95M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -167.95M |
| FCF Per Share | -$1.25 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DFTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.22% |
| Shareholder Yield | -22.22% |
| Earnings Yield | -6.08% |
| FCF Yield | -2.89% |
Analyst Forecast
The average price target for DFTX is $67.47, which is 55.93% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $67.47 |
| Price Target Difference | 55.93% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 29, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Aug 29, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |